Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/1989
04/05/1989EP0309971A2 New spergualin-related compound and pharmaceutical composition
04/05/1989EP0309863A2 Composition and method to release an immune reaction to GnRH and method for the immunosterilization of mammals
04/05/1989EP0309841A2 Amino acid derivatives
04/05/1989EP0309787A2 Process for producing a highly purified, virus-free and biologically active transferrin preparation
04/05/1989EP0309602A1 Use of catabolic enzymes for the manufacture of a medicament in the treatment of AIDS and its early stages (LAS, ARC)
04/05/1989EP0309569A1 Production of purified, biologically active, bacterially produced recombinant human csf-1
04/05/1989EP0309548A1 Human tissue factor related dna segments, polypeptides and antibodies
04/04/1989US4818769 Method of controlling stress-related disease in livestock by administration of human IL-2
04/04/1989US4818763 Immunostimulants
04/04/1989US4818749 Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure
04/04/1989US4818698 Polypeptides and preparation process thereof
04/04/1989US4818689 Late differentiation antigen associated with helper T lymphocyte function
04/04/1989US4818538 Treatment of human viral infections
04/04/1989US4818531 Growth hormone and thyroid hormone
04/04/1989US4818516 Method of nutritional assessment and therapy
03/1989
03/30/1989DE3830245A1 Calcitonins
03/30/1989DE3731875A1 Gentechnische herstellung von neukombinierten plasmiden fuer die produktion von humanem adrenocorticotropen horman (acth) und davon abgeleiteten derivaten durch enzymatische spaltung primaer synthetisierter fusionsproteine Genetic manufacture of recombined plasmids for the production of human adrenocorticotropic horman (acth) and derived by enzymatic cleavage derivatives synthesized fusion proteins primaer
03/30/1989DE3730556A1 Multilipid-based medicine
03/29/1989EP0309324A1 Process for the preparation of N-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides
03/29/1989EP0309297A2 Therapeutic peptides
03/29/1989EP0309241A2 Inductive collagen-based bone repair preparations
03/29/1989EP0309161A2 Antibiotic compounds
03/29/1989EP0309120A2 Atrial hypotensive peptide
03/29/1989EP0309111A2 A process for obtaining higher yields of unaggregated tissue plasminogen activator from cell culture
03/29/1989EP0309100A2 Use of amylin or CGRP for the treatment of diabetes mellitus
03/29/1989EP0309050A1 Human insulin-like growth factor analogs with reduced binding to serum carrier proteins and their production in yeast
03/29/1989EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells
03/29/1989EP0308725A2 Pharmaceutical composition for intrarectal administration of a calcitonin and unit dosage forms prepared therefrom
03/29/1989EP0308724A2 Use of a immunistimulating biologic to manufacture a medicament to treat human immunodeficiency virus
03/29/1989EP0308717A2 Method of treating viral encephalitis
03/29/1989EP0308716A2 Modified plasminogen activators
03/29/1989EP0308456A1 Compositon for the treatment of the epiderm.
03/29/1989EP0308424A1 A novel protein, neuroleukin
03/29/1989EP0160015B1 Preparation for rehydrating monogastric animals, including human beings, suffering from diarrhoea and use thereof
03/29/1989EP0144367B1 Method and reagent for the direct detection of an analyte after the specific elimination of colloidal particles in aqueous solutions of biological origin
03/29/1989CN1032014A Ring groth hormone releasing factor (grf), analogue and its process
03/29/1989CN1031940A Trans-mucosal delivery formulations and method for preparation thereof
03/28/1989US4816568 Stabilization of growth hormones
03/28/1989US4816566 Viricides
03/28/1989US4816565 Interleukin 2 receptor and a method for production thereof
03/28/1989US4816563 Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
03/28/1989US4816561 Biologically active polypeptides
03/28/1989US4816560 Storage stability
03/28/1989US4816559 Biologically active peptides TAN-866
03/28/1989US4816482 Radioprotective agents having an amino-thioalkyl structure
03/28/1989US4816466 Piperidine derivatives
03/28/1989US4816450 Antiinflammatory agents, amine compounds
03/28/1989US4816449 Immunotherapeutic anti-inflammatory peptide agents
03/28/1989US4816444 Cell growth inhibitory substance
03/28/1989US4816443 Piptides having ANF activity
03/28/1989US4816442 Method of inhibiting tumor growth sensitive to CIF-βtreatment
03/28/1989US4816441 Anticarcinogenic agents, viricides
03/28/1989US4816440 Interleukins, sodium laurate
03/28/1989US4816439 The use of human growth hormone for the treatment of intoxicated individuals
03/28/1989US4816438 Insulin-selective somatostatin analogs
03/28/1989US4816437 Calcium deficiency, glycoproteins
03/28/1989US4816436 Anti-arthritic use of interleukin-1 proteins
03/28/1989US4816404 Monoclonal antibodies producing hybridomas
03/28/1989US4816398 Bivalent cations
03/28/1989US4816397 Genetic engineering
03/28/1989US4816251 Tissue adhesives, heat treatment, vacuum
03/28/1989US4816249 Monoclonal anti-idiotype antibodies
03/28/1989CA1251898A1 Pharmaceutical peptides, their preparation and use
03/28/1989CA1251733A1 Combination of dihydropyridines with ace inhibitors and their use in medicaments
03/28/1989CA1251732A1 Pharmaceutical compositions comprising an antiprogestomimetic substance and a uterotonic substance
03/23/1989WO1989002600A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
03/23/1989WO1989002599A1 Detection of survived, undegraded carbohydrate epitopes as diagnostic of intestinal diseases
03/23/1989WO1989002468A1 Transduced fibroblasts and uses therefor
03/23/1989WO1989002467A1 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
03/23/1989WO1989002465A2 Polypeptide production
03/23/1989WO1989002462A1 Recombinant plasmids for producing human adrenocorticotropic hormone (acth)
03/23/1989WO1989002443A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
03/23/1989WO1989002442A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
03/23/1989WO1989002441A1 Antibiotic compounds
03/23/1989WO1989002279A1 Trans-mucosal delivery formulations and a method for preparation thereof
03/23/1989WO1989002276A1 Use of a tripeptide for the preparation of pharmaceutical compositions and a pharmaceutical composition and method
03/23/1989WO1989002275A1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
03/23/1989WO1989001973A3 Recombinant pox virus for immunization against tumor-associated antigens
03/23/1989EP0222003A4 MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR).
03/22/1989EP0308386A1 New medical use
03/22/1989EP0308381A1 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same
03/22/1989EP0308378A2 Tumor necrosis factor (TNF)inhibitory protein and its purification
03/22/1989EP0308341A1 Process for the industrial synthesis of perindopril and for its principal synthesis intermediates
03/22/1989EP0308337A2 4-Aminopyridine derivatives and their acid addition salts
03/22/1989EP0308319A2 4-Piperidinecarboxamide derivatives
03/22/1989EP0308265A2 Methods and compositions relating to regression-associated antigens
03/22/1989EP0308239A2 Method for reducing bacterial endotoxin contamination in solutions of macromolecules
03/22/1989EP0308238A1 Stable lyophilized formulations containing growth factors
03/22/1989EP0308208A1 Modified antibody conjugates with enhanced clearance
03/22/1989EP0308197A2 Method for stimulating the immune system
03/22/1989EP0308181A1 Trans-mucosal delivery formulations and a method for preparation thereof
03/22/1989EP0308066A2 Promotion of host defense by systemic dsRNA treatment
03/22/1989EP0307872A2 Esters of amino-acids, process for their preparation, medicaments containing them and their use
03/22/1989EP0307860A2 Cyclic GRF-analogs
03/22/1989EP0307857A1 Stabilization of therapeutically active proteins in pharmaceutical preparations
03/22/1989EP0307847A2 Thrombolytic agent
03/22/1989EP0307837A2 Renin-inhibiting peptidyl heterocycles
03/22/1989EP0307662A2 Enkephalin analogs
03/22/1989EP0307592A2 Analogues of the pancreatic bovine trypsin inhibitor, their production and use
03/22/1989EP0307553A2 Modified splenopentines, their process of preparation and their use
1 ... 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 ... 3163